Global Market Report

Molecular Diagnostics (MDx) Market Report 2020-2030

Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level.

SKU: PHA0543 Category: Tags: , , , Code: PHA0543Pages: 174
Clear
← Back to category Diagnostics

Description

Molecular Diagnostics, our new study reveals trends, R&D progress, and predicted revenues
Where is the Molecular Diagnostics market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.

Discover how to stay ahead
Our 166-page report provides 35 tables, 141 charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Molecular Diagnostics market. See how to exploit the opportunities.

Forecasts to 2030 and other analyses reveal the commercial prospects
– In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares.
– You find original analyses, with business outlooks and developments.
– Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

Discover sales predictions for the world market and submarkets
Along with revenue prediction for the overall world market, there are 4 segmentations of the Molecular Diagnostics Market, with forecasts for 3 Products and Services, 5 Technologies, 4 Applications, 3 End Users, each forecasted at a global and regional level.

Global Molecular Diagnostics Market by Products and Services
– Instruments
– Reagents & Kits
– Software and Services

Global Molecular Diagnostics Market by Technology
– DNA Microarray
– In Situ Hybridization
– Isothermal Nucleic Acid Amplification Technology (INAAT)
– DNA Sequencing & Next-Generation Sequencing (NGS)
– Other Technologies

Global Molecular Diagnostics Market by Application
– Genetic Tests
– Infectious Diseases
– CT/NG
– HAIS
– Hepatitis
– HIV
– HPV
– Influenza
– Tuberculosis
– Other Infectious Diseases
– Oncology
– Breast Cancer
– Colorectal Cancer
– Lung Cancer
– Prostate Cancer
– Other Cancers
– Other Applications

Global Molecular Diagnostics Market by End User
– Hospitals & Academics
– Research Laboratories
– Other End Users

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 6 regional and 21 leading national markets:

– North America:
– US
– Canada

– Latin America:
– Brazil
– Mexico
– Rest of Latin America

– Western Europe:
– Germany
– The UK
– Italy
– France
– Spain
– Nordic
– Benelux
– Rest of Western Europe

– Eastern Europe:
– Russia
– Poland
– Rest of Eastern Europe

– Asia-Pacific:
– Japan
– China
– India
– Australia & New Zealand
– ASEAN
– Rest of Asia-Pacific

– MEA:
– GCC Countries
– South Africa
– Northern Africa
– Rest of MEA

The report also includes profiles and for some of the leading companies in the Molecular Diagnostics Market, with a focus on this segment of these companies’ operations.

There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, Russia, Germany and China in particular, will continue to achieve high revenue growth to 2030.

Leading companies and the potential for market growth
Overall world revenue for Molecular Diagnostics will surpass $8.5 bn in 2020, our work calculates. We predict strong revenue growth through to 2030.

Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Molecular Diagnostics Market report helps you
In summary, our 166-page report provides you with the following knowledge:

– Revenue forecasts to 2030 for 4 segmentations of the Molecular Diagnostics Market, with forecasts for 3 Products and Services, 5 Technologies, 4 Applications, 3 End Users, each forecasted at a global and regional level, discover the industry’s prospects, finding the most lucrative places for investments and revenues

– Revenue forecasts to 2030 for 6 regional and 21 key national markets , See forecasts for the Molecular Diagnostics market in North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, the UK, Italy, France, Nordic Countries, Benelux, China, India, Japan, Australia & New Zealand, ASEAN countries, GCC Countries, South Africa and Northern Africa.

– Stimulates and restrains companies and the market

– Prospects for established firms and those seeking to enter the market, including company profiles for 17 of the major companies involved in the Molecular Diagnostics market
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.

Visiongain’s study is for everybody needing commercial analyses for the Molecular Diagnostics market and leading companies. You will find data, trends and predictions.

Get our report today The Molecular Diagnostics Market Forecast 2020-2030: Revenue Prospects by Products and Services (Instruments, Reagents & Kits, Software and Services), Technology (DNA Microarray, In Situ Hybridization, Isothermal Nucleic Acid Amplification Technology (INAAT), DNA Sequencing & Next-Generation Sequencing (NGS), Other Technologies), Application (Genetic Tests, Infectious Diseases, Oncology, Other Applications), End User (Hospitals & Academics, Research Laboratories, Other End Users), and Geography.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com

1. Report Overview
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered by This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain

2. Molecular Diagnostics Market Overview
2.1. Introduction
2.1.1. Market Definition
2.1.2. Market Taxonomy
2.2. Global Molecular Diagnostics Market Size and Forecast
2.3. Market Dynamics
2.3.1. Market Drivers
2.3.1.1. Increasing Awareness and Acceptance of Personalized Medicine and Companion Diagnostics
2.3.1.2. Introduction of technologically advanced products
2.3.1.3. Growing prevalence of target diseases
2.3.1.4. Increasing Demand for Point-of-care Diagnostics
2.3.1.5. Growing Demand for Patient-Centric Healthcare
2.3.1.6. Recent Advancements in Pharmacogenomics
2.3.2. Market Restraints
2.3.2.1. Limited Budgets for R&D
2.3.2.2. Complex Regulatory Frameworks
2.3.3. Global Molecular Diagnostics Market: Trends
2.3.4. Mergers and Acquisitions
2.3.5. Entry of New Market Players

3. Global Molecular Diagnostics Market Analysis and Forecast, By Products and Services
3.1. Introduction
3.1.1. Global Molecular Diagnostics Market, Annual Growth Rate Comparison, By Products and Services
3.2. Global Molecular Diagnostics Market Size and Forecast, By Products and Services
3.2.1. Instruments
3.2.2. Reagents & Kits
3.2.3. Software and Services
3.3. Global Molecular Diagnostics Attractiveness Index, By Products and Services

4. Global Molecular Diagnostics Market Analysis and Forecast, By Technology
4.1. Introduction
4.1.1. Global Molecular Diagnostics Market, Annual Growth Rate Comparison, By Technology
4.1.2. Global Molecular Diagnostics Market Share Comparison, By Technology (2018 & 2030)
4.2. Global Molecular Diagnostics Market Size and Forecast, By Technology
4.2.1. DNA Microarray
4.2.2. In Situ Hybridization
4.2.3. Isothermal Nucleic Acid Amplification Technology (INAAT)
4.2.4. DNA Sequencing & Next-Generation Sequencing (NGS)
4.2.5. Other Technologies
4.3. Global Molecular Diagnostics Attractiveness Index, By Technology

5. Global Molecular Diagnostics Market Analysis and Forecast, By Application
5.1. Introduction
5.1.1. Global Molecular Diagnostics Market, Annual Growth Rate Comparison, By Application
5.1.2. Global Molecular Diagnostics Market Share Comparison, By Application (2018 & 2030)
5.2. Global Molecular Diagnostics Market Size and Forecast, By Application
5.2.1. Genetic Tests
5.2.2. Infectious Diseases
5.2.2.1. CT/NG
5.2.2.2. HAIS
5.2.2.3. Hepatitis
5.2.2.4. HIV
5.2.2.5. HPV
5.2.2.6. Influenza
5.2.2.7. Tuberculosis
5.2.2.8. Other Infectious Diseases
5.2.3. Oncology
5.2.3.1. Breast Cancer
5.2.3.2. Colorectal Cancer
5.2.3.3. Lung Cancer
5.2.3.4. Prostate Cancer
5.2.3.5. Other Cancers
5.2.4. Other Applications
5.3. Global Molecular Diagnostics Attractiveness Index, By Application

6. Global Molecular Diagnostics Market Analysis and Forecast, By End User
6.1. Introduction
6.1.1. Global Molecular Diagnostics Market, Annual Growth Rate Comparison, By End User
6.1.2. Global Molecular Diagnostics Market Share Comparison, By End User (2018 & 2030)
6.2. Global Molecular Diagnostics Market Size and Forecast, By End User
6.2.1. Hospitals & Academics
6.2.2. Research Laboratories
6.2.3. Other End Users
6.3. Global Molecular Diagnostics Attractiveness Index, By End User

7. Global Molecular Diagnostics Market Analysis and Forecast, By Region
7.1. Introduction
7.1.1. Global Molecular Diagnostics Market, Annual Growth Rate Comparison, By Region
7.1.2. Global Molecular Diagnostics Market Share Comparison, By Region (2018 & 2030)
7.2. Global Molecular Diagnostics Market Size and Forecast, By Region
7.2.1. North America (U.S., Canada)
7.2.2. Latin America (Brazil, Mexico, Rest of Latin America)
7.2.3. Western Europe (UK, France, Germany, Italy, Spain, Nordic, Benelux, RoWE)
7.2.4. Eastern Europe (Russia, Poland, Rest of Eastern Europe)
7.2.5. Asia Pacific (Japan, China, India, ASEAN, Australia, RoAPAC)
7.2.6. MEA (GCC, South Africa, North Africa, RoMEA)
7.3. Global Molecular Diagnostics Market Attractiveness Index, By Region

8. North America Molecular Diagnostics Market Analysis and Forecast, 2020-2030
8.1. Introduction
8.1.1. North America Molecular Diagnostics Market
8.1.2. North America Molecular Diagnostics Market, Annual Growth Rate Comparison, By Country
8.2. North America Molecular Diagnostics Market Size and Forecast, By Country
8.2.1. The U.S. Molecular Diagnostics Market
8.2.2. Canada Molecular Diagnostics Market
8.3. North America Molecular Diagnostics Market Size and Forecast, By Products and Services
8.4. North America Molecular Diagnostics Market Size and Forecast, By Technology
8.5. North America Molecular Diagnostics Market Size and Forecast, By Application
8.6. North America Molecular Diagnostics Market Size and Forecast, By End User
8.7. North America Molecular Diagnostics Market Attractiveness Index
8.8. North America Molecular Diagnostics Market Attractiveness Index, By Country
8.9. North America Molecular Diagnostics Market Attractiveness Index, By Products and Services
8.10. North America Molecular Diagnostics Market Attractiveness Index, By Technology
8.11. North America Molecular Diagnostics Market Attractiveness Index, By Application
8.12. North America Molecular Diagnostics Market Attractiveness Index, By End User

9. Latin America Molecular Diagnostics Market Analysis and Forecast, 2020-2030
9.1. Introduction
9.1.1. Latin America Molecular Diagnostics Market
9.1.2. Latin America Molecular Diagnostics Market, Annual Growth Rate Comparison, By Country
9.2. Latin America Molecular Diagnostics Market Size and Forecast, By Country
9.2.1. Brazil Molecular Diagnostics Market
9.2.2. Mexico Molecular Diagnostics Market
9.2.3. Rest of Latin America Molecular Diagnostics Market
9.3. Latin America Molecular Diagnostics Market Size and Forecast, By Products and Services
9.4. Latin America Molecular Diagnostics Market Size and Forecast, By Technology
9.5. Latin America Molecular Diagnostics Market Size and Forecast, By Application
9.6. Latin America Molecular Diagnostics Market Size and Forecast, By End User
9.7. Latin America Molecular Diagnostics Market Attractiveness Index
9.8. Latin America Molecular Diagnostics Market Attractiveness Index, By Country
9.9. Latin America Molecular Diagnostics Market Attractiveness Index, By Products and Services
9.10. Latin America Molecular Diagnostics Market Attractiveness Index, By Technology
9.11. Latin America Molecular Diagnostics Market Attractiveness Index, By Application
9.12. Latin America Molecular Diagnostics Market Attractiveness Index, By End User

10. Western Europe Molecular Diagnostics Market Analysis and Forecast, 2020-2030
10.1. Introduction
10.1.1. Western Europe Molecular Diagnostics Market
10.1.2. Western Europe Molecular Diagnostics Market, Annual Growth Rate Comparison, By Country
10.2. Western Europe Molecular Diagnostics Market Size and Forecast, By Country
10.2.1. U.K. Molecular Diagnostics Market
10.2.2. France Molecular Diagnostics Market
10.2.3. Germany Molecular Diagnostics Market
10.2.4. Italy Molecular Diagnostics Market
10.2.5. Spain Molecular Diagnostics Market
10.2.6. Nordic Molecular Diagnostics Market
10.2.7. Benelux Molecular Diagnostics Market
10.2.8. Rest of Western Europe Molecular Diagnostics Market
10.3. Western Europe Molecular Diagnostics Market Size and Forecast, By Products and Services
10.4. Western Europe Molecular Diagnostics Market Size and Forecast, By Technology
10.5. Western Europe Molecular Diagnostics Market Size and Forecast, By Application
10.6. Western Europe Molecular Diagnostics Market Size and Forecast, By End User
10.7. Western Europe Molecular Diagnostics Market Attractiveness Index
10.8. Western Europe Molecular Diagnostics Market Attractiveness Index, By Country
10.9. Western Europe Molecular Diagnostics Market Attractiveness Index, By Products and Services
10.10. Western Europe Molecular Diagnostics Market Attractiveness Index, By Technology
10.11. Western Europe Molecular Diagnostics Market Attractiveness Index, By Application
10.12. Western Europe Molecular Diagnostics Market Attractiveness Index, By End User

11. Eastern Europe Molecular Diagnostics Market Analysis and Forecast, 2020-2030
11.1. Introduction
11.1.1. Eastern Europe Molecular Diagnostics Market
11.1.2. Eastern Europe Molecular Diagnostics Market, Annual Growth Rate Comparison, By Country
11.2. Eastern Europe Molecular Diagnostics Market Size and Forecast, By Country
11.2.1. Russia Molecular Diagnostics Market
11.2.2. Poland Molecular Diagnostics Market
11.2.3. Rest of Eastern Europe Molecular Diagnostics Market
11.3. Eastern Europe Molecular Diagnostics Market Size and Forecast, By Products and Services
11.4. Eastern Europe Molecular Diagnostics Market Size and Forecast, By Technology
11.5. Eastern Europe Molecular Diagnostics Market Size and Forecast, By Application
11.6. Eastern Europe Molecular Diagnostics Market Size and Forecast, By End User
11.7. Eastern Europe Molecular Diagnostics Market Attractiveness Index
11.8. Eastern Europe Molecular Diagnostics Market Attractiveness Index, By Country
11.9. Eastern Europe Molecular Diagnostics Market Attractiveness Index, By Products and Services
11.10. Eastern Europe Molecular Diagnostics Market Attractiveness Index, By Technology
11.11. Eastern Europe Molecular Diagnostics Market Attractiveness Index, By Application
11.12. Eastern Europe Molecular Diagnostics Market Attractiveness Index, By End User

12. Asia Pacific Molecular Diagnostics Market Analysis and Forecast, 2020-2030
12.1. Introduction
12.1.1. Asia Pacific Molecular Diagnostics Market
12.1.2. Asia Pacific Molecular Diagnostics Market, Annual Growth Rate Comparison, By Country
12.2. Asia Pacific Molecular Diagnostics Market Size and Forecast, By Country
12.2.1. China Molecular Diagnostics Market
12.2.2. India Molecular Diagnostics Market
12.2.3. Australia Molecular Diagnostics Market
12.2.4. ASEAN Molecular Diagnostics Market
12.2.5. Japan Molecular Diagnostics Market
12.2.6. Rest of Asia Pacific Molecular Diagnostics Market
12.3. Asia Pacific Molecular Diagnostics Market Size and Forecast, By Products and Services
12.4. Asia Pacific Molecular Diagnostics Market Size and Forecast, By Technology
12.5. Asia Pacific Molecular Diagnostics Market Size and Forecast, By Application
12.6. Asia Pacific Molecular Diagnostics Market Size and Forecast, By End User
12.7. Asia Pacific Molecular Diagnostics Market Attractiveness Index
12.8. Asia Pacific Molecular Diagnostics Market Attractiveness Index, By Country
12.9. Asia Pacific Molecular Diagnostics Market Attractiveness Index, By Products and Services
12.10. Asia Pacific Molecular Diagnostics Market Attractiveness Index, By Technology
12.11. Asia Pacific Molecular Diagnostics Market Attractiveness Index, By Application
12.12. Asia Pacific Molecular Diagnostics Market Attractiveness Index, By End User

13. MEA Molecular Diagnostics Market Analysis and Forecast, 2020-2030
13.1. Introduction
13.1.1. MEA Molecular Diagnostics Market
13.1.2. MEA Molecular Diagnostics Market, Annual Growth Rate Comparison, By Country
13.2. MEA Molecular Diagnostics Market Size and Forecast, By Country
13.2.1. GCC Molecular Diagnostics Market
13.2.2. South Africa Molecular Diagnostics Market
13.2.3. North Africa Molecular Diagnostics Market
13.2.4. Rest of MEA Molecular Diagnostics Market
13.3. MEA Molecular Diagnostics Market Size and Forecast, By Products and Services
13.4. MEA Molecular Diagnostics Market Size and Forecast, By Technology
13.5. MEA Molecular Diagnostics Market Size and Forecast, By Application
13.6. MEA Molecular Diagnostics Market Size and Forecast, By End User
13.7. MEA Molecular Diagnostics Market Attractiveness Index
13.8. MEA Molecular Diagnostics Market Attractiveness Index, By Country
13.9. MEA Molecular Diagnostics Market Attractiveness Index, By Products and Services
13.10. MEA Molecular Diagnostics Market Attractiveness Index, By Technology
13.11. MEA Molecular Diagnostics Market Attractiveness Index, By Application
13.12. MEA Molecular Diagnostics Market Attractiveness Index, By End User

14. Leading Companies in the Molecular Diagnostics Market
14.1. Competition Dashboard
14.2. Company Share Analysis
14.3. Company Profiling of 17 Major Players
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance (2016-2018)
14.3.4. Recent Initiatives

15. Conclusion

16. Glossary

17. List of Figures
Figure1. Research design
Figure2. Market segmentation & scope
Figure3. Value chain analysis
Figure4. Porter's Five Forces
Figure5. Market driver analysis (Current & Future Impact)
Figure6. Market restraint analysis (Current & Future Impact)
Figure7. Global Molecular Diagnostics Market by Products and Services, 2020-2030 (USD million)
Figure8. Global Molecular Diagnostics Market for Instruments, 2020-2030 (USD million)
Figure9. Global Molecular Diagnostics Market for Reagents & Kits, 2020-2030 (USD million)
Figure10. Global Molecular Diagnostics Market for Software and Services, 2020-2030 (USD million)
Figure11. Global Molecular Diagnostics Market by Technology, 2020-2030 (USD million)
Figure12. Global Molecular Diagnostics Market for DNA Microarray, 2020-2030 (USD million)
Figure13. Global Molecular Diagnostics Market for In Situ Hybridization, 2020-2030 (USD million)
Figure14. Global Molecular Diagnostics Market for Isothermal Nucleic Acid Amplification Technology (INAAT), 2020-2030 (USD million)
Figure15. Global Molecular Diagnostics Market for DNA Sequencing & Next-Generation Sequencing (NGS), 2020-2030 (USD million)
Figure16. Global Molecular Diagnostics Market for Other Technologies, 2020-2030 (USD million)
Figure17. Global Molecular Diagnostics Market by Application, 2020-2030 (USD million)
Figure18. Global Molecular Diagnostics Market for Genetic Tests, 2020-2030 (USD million)
Figure19. Global Molecular Diagnostics Market for Infectious Diseases, 2020-2030 (USD million)
Figure20. Global Molecular Diagnostics Market for Oncology, 2020-2030 (USD million)
Figure21. Global Molecular Diagnostics Market for Other Applications, 2020-2030 (USD million)
Figure22. Global Molecular Diagnostics Market by End User, 2020-2030 (USD million)
Figure23. Global Molecular Diagnostics Market for Hospitals & Academics, 2020-2030 (USD million)
Figure24. Global Molecular Diagnostics Market for Research Laboratories, 2020-2030 (USD million)
Figure25. Global Molecular Diagnostics Market for Other End Users, 2020-2030 (USD million)
Figure26. North America Molecular Diagnostics Market by Products and Services, 2020-2030 (USD million)
Figure27. North America Molecular Diagnostics Market for Instruments, 2020-2030 (USD million)
Figure28. North America Molecular Diagnostics Market for Reagents & Kits, 2020-2030 (USD million)
Figure29. North America Molecular Diagnostics Market for Software and Services, 2020-2030 (USD million)
Figure30. North America Molecular Diagnostics Market by Technology, 2020-2030 (USD million)
Figure31. North America Molecular Diagnostics Market for DNA Microarray, 2020-2030 (USD million)
Figure32. North America Molecular Diagnostics Market for In Situ Hybridization, 2020-2030 (USD million)
Figure33. North America Molecular Diagnostics Market for Isothermal Nucleic Acid Amplification Technology (INAAT), 2020-2030 (USD million)
Figure34. North America Molecular Diagnostics Market for DNA Sequencing & Next-Generation Sequencing (NGS), 2020-2030 (USD million)
Figure35. North America Molecular Diagnostics Market for Other Technologies, 2020-2030 (USD million)
Figure36. North America Molecular Diagnostics Market by Application, 2020-2030 (USD million)
Figure37. North America Molecular Diagnostics Market for Genetic Tests, 2020-2030 (USD million)
Figure38. North America Molecular Diagnostics Market for Infectious Diseases, 2020-2030 (USD million)
Figure39. North America Molecular Diagnostics Market for Oncology, 2020-2030 (USD million)
Figure40. North America Molecular Diagnostics Market for Other Applications, 2020-2030 (USD million)
Figure41. North America Molecular Diagnostics Market by End User, 2020-2030 (USD million)
Figure42. North America Molecular Diagnostics Market for Hospitals & Academics, 2020-2030 (USD million)
Figure43. North America Molecular Diagnostics Market for Research Laboratories, 2020-2030 (USD million)
Figure44. North America Molecular Diagnostics Market for Other End Users, 2020-2030 (USD million)
Figure45. Latin America Molecular Diagnostics Market by Products and Services, 2020-2030 (USD million)
Figure46. Latin America Molecular Diagnostics Market for Instruments, 2020-2030 (USD million)
Figure47. Latin America Molecular Diagnostics Market for Reagents & Kits, 2020-2030 (USD million)
Figure48. Latin America Molecular Diagnostics Market for Software and Services, 2020-2030 (USD million)
Figure49. Latin America Molecular Diagnostics Market by Technology, 2020-2030 (USD million)
Figure50. Latin America Molecular Diagnostics Market for DNA Microarray, 2020-2030 (USD million)
Figure51. Latin America Molecular Diagnostics Market for In Situ Hybridization, 2020-2030 (USD million)
Figure52. Latin America Molecular Diagnostics Market for Isothermal Nucleic Acid Amplification Technology (INAAT), 2020-2030 (USD million)
Figure53. Latin America Molecular Diagnostics Market for DNA Sequencing & Next-Generation Sequencing (NGS), 2020-2030 (USD million)
Figure54. Latin America Molecular Diagnostics Market for Other Technologies, 2020-2030 (USD million)
Figure55. Latin America Molecular Diagnostics Market by Application, 2020-2030 (USD million)
Figure56. Latin America Molecular Diagnostics Market for Genetic Tests, 2020-2030 (USD million)
Figure57. Latin America Molecular Diagnostics Market for Infectious Diseases, 2020-2030 (USD million)
Figure58. Latin America Molecular Diagnostics Market for Oncology, 2020-2030 (USD million)
Figure59. Latin America Molecular Diagnostics Market for Other Applications, 2020-2030 (USD million)
Figure60. Latin America Molecular Diagnostics Market by End User, 2020-2030 (USD million)
Figure61. Latin America Molecular Diagnostics Market for Hospitals & Academics, 2020-2030 (USD million)
Figure62. Latin America Molecular Diagnostics Market for Research Laboratories, 2020-2030 (USD million)
Figure63. Latin America Molecular Diagnostics Market for Other End Users, 2020-2030 (USD million)
Figure64. Western Europe Molecular Diagnostics Market by Products and Services, 2020-2030 (USD million)
Figure65. Western Europe Molecular Diagnostics Market for Instruments, 2020-2030 (USD million)
Figure66. Western Europe Molecular Diagnostics Market for Reagents & Kits, 2020-2030 (USD million)
Figure67. Western Europe Molecular Diagnostics Market for Software and Services, 2020-2030 (USD million)
Figure68. Western Europe Molecular Diagnostics Market by Technology, 2020-2030 (USD million)
Figure69. Western Europe Molecular Diagnostics Market for DNA Microarray, 2020-2030 (USD million)
Figure70. Western Europe Molecular Diagnostics Market for In Situ Hybridization, 2020-2030 (USD million)
Figure71. Western Europe Molecular Diagnostics Market for Isothermal Nucleic Acid Amplification Technology (INAAT), 2020-2030 (USD million)
Figure72. Western Europe Molecular Diagnostics Market for DNA Sequencing & Next-Generation Sequencing (NGS), 2020-2030 (USD million)
Figure73. Western Europe Molecular Diagnostics Market for Other Technologies, 2020-2030 (USD million)
Figure74. Western Europe Molecular Diagnostics Market by Application, 2020-2030 (USD million)
Figure75. Western Europe Molecular Diagnostics Market for Genetic Tests, 2020-2030 (USD million)
Figure76. Western Europe Molecular Diagnostics Market for Infectious Diseases, 2020-2030 (USD million)
Figure77. Western Europe Molecular Diagnostics Market for Oncology, 2020-2030 (USD million)
Figure78. Western Europe Molecular Diagnostics Market for Other Applications, 2020-2030 (USD million)
Figure79. Western Europe Molecular Diagnostics Market by End User, 2020-2030 (USD million)
Figure80. Western Europe Molecular Diagnostics Market for Hospitals & Academics, 2020-2030 (USD million)
Figure81. Western Europe Molecular Diagnostics Market for Research Laboratories, 2020-2030 (USD million)
Figure82. Western Europe Molecular Diagnostics Market for Other End Users, 2020-2030 (USD million)
Figure83. Eastern Europe Molecular Diagnostics Market by Products and Services, 2020-2030 (USD million)
Figure84. Eastern Europe Molecular Diagnostics Market for Instruments, 2020-2030 (USD million)
Figure85. Eastern Europe Molecular Diagnostics Market for Reagents & Kits, 2020-2030 (USD million)
Figure86. Eastern Europe Molecular Diagnostics Market for Software and Services, 2020-2030 (USD million)
Figure87. Eastern Europe Molecular Diagnostics Market by Technology, 2020-2030 (USD million)
Figure88. Eastern Europe Molecular Diagnostics Market for DNA Microarray, 2020-2030 (USD million)
Figure89. Eastern Europe Molecular Diagnostics Market for In Situ Hybridization, 2020-2030 (USD million)
Figure90. Eastern Europe Molecular Diagnostics Market for Isothermal Nucleic Acid Amplification Technology (INAAT), 2020-2030 (USD million)
Figure91. Eastern Europe Molecular Diagnostics Market for DNA Sequencing & Next-Generation Sequencing (NGS), 2020-2030 (USD million)
Figure92. Eastern Europe Molecular Diagnostics Market for Other Technologies, 2020-2030 (USD million)
Figure93. Eastern Europe Molecular Diagnostics Market by Application, 2020-2030 (USD million)
Figure94. Eastern Europe Molecular Diagnostics Market for Genetic Tests, 2020-2030 (USD million)
Figure95. Eastern Europe Molecular Diagnostics Market for Infectious Diseases, 2020-2030 (USD million)
Figure96. Eastern Europe Molecular Diagnostics Market for Oncology, 2020-2030 (USD million)
Figure97. Eastern Europe Molecular Diagnostics Market for Other Applications, 2020-2030 (USD million)
Figure98. Eastern Europe Molecular Diagnostics Market by End User, 2020-2030 (USD million)
Figure99. Eastern Europe Molecular Diagnostics Market for Hospitals & Academics, 2020-2030 (USD million)
Figure100. Eastern Europe Molecular Diagnostics Market for Research Laboratories, 2020-2030 (USD million)
Figure101. Eastern Europe Molecular Diagnostics Market for Other End Users, 2020-2030 (USD million)
Figure102. APAC Molecular Diagnostics Market by Products and Services, 2020-2030 (USD million)
Figure103. APAC Molecular Diagnostics Market for Instruments, 2020-2030 (USD million)
Figure104. APAC Molecular Diagnostics Market for Reagents & Kits, 2020-2030 (USD million)
Figure105. APAC Molecular Diagnostics Market for Software and Services, 2020-2030 (USD million)
Figure106. APAC Molecular Diagnostics Market by Technology, 2020-2030 (USD million)
Figure107. APAC Molecular Diagnostics Market for DNA Microarray, 2020-2030 (USD million)
Figure108. APAC Molecular Diagnostics Market for In Situ Hybridization, 2020-2030 (USD million)
Figure109. APAC Molecular Diagnostics Market for Isothermal Nucleic Acid Amplification Technology (INAAT), 2020-2030 (USD million)
Figure110. APAC Molecular Diagnostics Market for DNA Sequencing & Next-Generation Sequencing (NGS), 2020-2030 (USD million)
Figure111. APAC Molecular Diagnostics Market for Other Technologies, 2020-2030 (USD million)
Figure112. APAC Molecular Diagnostics Market by Application, 2020-2030 (USD million)
Figure113. APAC Molecular Diagnostics Market for Genetic Tests, 2020-2030 (USD million)
Figure114. APAC Molecular Diagnostics Market for Infectious Diseases, 2020-2030 (USD million)
Figure115. APAC Molecular Diagnostics Market for Oncology, 2020-2030 (USD million)
Figure116. APAC Molecular Diagnostics Market for Other Applications, 2020-2030 (USD million)
Figure117. APAC Molecular Diagnostics Market by End User, 2020-2030 (USD million)
Figure118. APAC Molecular Diagnostics Market for Hospitals & Academics, 2020-2030 (USD million)
Figure119. APAC Molecular Diagnostics Market for Research Laboratories, 2020-2030 (USD million)
Figure120. APAC Molecular Diagnostics Market for Other End Users, 2020-2030 (USD million)
Figure121. MEA Molecular Diagnostics Market by Products and Services, 2020-2030 (USD million)
Figure122. MEA Molecular Diagnostics Market for Instruments, 2020-2030 (USD million)
Figure123. MEA Molecular Diagnostics Market for Reagents & Kits, 2020-2030 (USD million)
Figure124. MEA Molecular Diagnostics Market for Software and Services, 2020-2030 (USD million)
Figure125. MEA Molecular Diagnostics Market by Technology, 2020-2030 (USD million)
Figure126. MEA Molecular Diagnostics Market for DNA Microarray, 2020-2030 (USD million)
Figure127. MEA Molecular Diagnostics Market for In Situ Hybridization, 2020-2030 (USD million)
Figure128. MEA Molecular Diagnostics Market for Isothermal Nucleic Acid Amplification Technology (INAAT), 2020-2030 (USD million)
Figure129. MEA Molecular Diagnostics Market for DNA Sequencing & Next-Generation Sequencing (NGS), 2020-2030 (USD million)
Figure130. MEA Molecular Diagnostics Market for Other Technologies, 2020-2030 (USD million)
Figure131. MEA Molecular Diagnostics Market by Application, 2020-2030 (USD million)
Figure132. MEA Molecular Diagnostics Market for Genetic Tests, 2020-2030 (USD million)
Figure133. MEA Molecular Diagnostics Market for Infectious Diseases, 2020-2030 (USD million)
Figure134. MEA Molecular Diagnostics Market for Oncology, 2020-2030 (USD million)
Figure135. MEA Molecular Diagnostics Market for Other Applications, 2020-2030 (USD million)
Figure136. MEA Molecular Diagnostics Market by End User, 2020-2030 (USD million)
Figure137. MEA Molecular Diagnostics Market for Hospitals & Academics, 2020-2030 (USD million)
Figure138. MEA Molecular Diagnostics Market for Research Laboratories, 2020-2030 (USD million)
Figure139. MEA Molecular Diagnostics Market for Other End Users, 2020-2030 (USD million)
Figure140. List of Companies

18. List of Tables
Table1. Global Molecular Diagnostics Market, by Products and Services, 2020-2030 (USD million)
Table2. Global Molecular Diagnostics Market, by Technology, 2020-2030 (USD million)
Table3. Global Molecular Diagnostics Market, by Application, 2020-2030 (USD million)
Table4. Global Molecular Diagnostics Market, by End User, 2020-2030 (USD million)
Table5. North America Molecular Diagnostics Market, 2020-2030 (USD million)
Table6. U.S. Molecular Diagnostics Market, 2020-2030 (USD million)
Table7. Canada Molecular Diagnostics Market, 2020-2030 (USD million)
Table8. Latin America Molecular Diagnostics Market, 2020-2030 (USD million)
Table9. Brazil Molecular Diagnostics Market, 2020-2030 (USD million)
Table10. Mexico Molecular Diagnostics Market, 2020-2030 (USD million)
Table11. Rest of Latin America Molecular Diagnostics Market, 2020-2030 (USD million)
Table12. Western Europe Molecular Diagnostics Market, 2020-2030 (USD million)
Table13. UK Molecular Diagnostics Market, 2020-2030 (USD million)
Table14. France Molecular Diagnostics Market, 2020-2030 (USD million)
Table15. Germany Molecular Diagnostics Market, 2020-2030 (USD million)
Table16. Italy Molecular Diagnostics Market, 2020-2030 (USD million)
Table17. Nordic Molecular Diagnostics Market, 2020-2030 (USD million)
Table18. Benelux Molecular Diagnostics Market, 2020-2030 (USD million)
Table19. Rest of Western Europe Molecular Diagnostics Market, 2020-2030 (USD million)
Table20. Eastern Europe Molecular Diagnostics Market, 2020-2030 (USD million)
Table21. Russia Molecular Diagnostics Market, 2020-2030 (USD million)
Table22. Poland Molecular Diagnostics Market, 2020-2030 (USD million)
Table23. Rest of Eastern Europe Molecular Diagnostics Market, 2020-2030 (USD million)
Table24. Asia Pacific Molecular Diagnostics Market, 2020-2030 (USD million)
Table25. Japan Molecular Diagnostics Market, 2020-2030 (USD million)
Table26. India Molecular Diagnostics Market, 2020-2030 (USD million)
Table27. Australia Molecular Diagnostics Market, 2020-2030 (USD million)
Table28. ASEAN Molecular Diagnostics Market, 2020-2030 (USD million)
Table29. China Molecular Diagnostics Market, 2020-2030 (USD million)
Table30. Rest of Asia Pacific Molecular Diagnostics Market, 2020-2030 (USD million)
Table31. MEA Molecular Diagnostics Market, 2020-2030 (USD million)
Table32. South Africa Molecular Diagnostics Market, 2020-2030 (USD million)
Table33. North Africa Molecular Diagnostics Market, 2020-2030 (USD million)
Table34. GCC Molecular Diagnostics Market, 2020-2030 (USD million)
Table35. Rest of MEA Molecular Diagnostics Market, 2020-2030 (USD million)

1. Abbott
1.1. Company Overview
1.2. Product Offerings
1.3. Financial Performance (2016-2018)
1.4. Recent Initiatives

2. Becton, Dickinson and Company
2.1. Company Overview
2.2. Product Offerings
2.3. Financial Performance (2016-2018)
2.4. Recent Initiatives

3. bioMérieux SA
3.1. Company Overview
3.2. Product Offerings
3.3. Financial Performance (2016-2018)
3.4. Recent Initiatives

4. Bio-Rad Laboratories, Inc.
4.1. Company Overview
4.2. Product Offerings
4.3. Financial Performance (2016-2018)
4.4. Recent Initiatives

5. Cepheid
5.1. Company Overview
5.2. Product Offerings
5.3. Financial Performance (2016-2018)
5.4. Recent Initiatives

6. Dako
6.1. Company Overview
6.2. Product Offerings
6.3. Financial Performance (2016-2018)
6.4. Recent Initiatives

7. Danaher Corporation
7.1. Company Overview
7.2. Product Offerings
7.3. Financial Performance (2016-2018)
7.4. Recent Initiatives

8. F. Hoffmann-La Roche Ltd.
8.1. Company Overview
8.2. Product Offerings
8.3. Financial Performance (2016-2018)
8.4. Recent Initiatives

9. Hologic, Inc.
9.1. Company Overview
9.2. Product Offerings
9.3. Financial Performance (2016-2018)
9.4. Recent Initiatives

10. Illumina, Inc.
10.1. Company Overview
10.2. Product Offerings
10.3. Financial Performance (2016-2018)
10.4. Recent Initiatives

11. Johnson & Johnson Services, Inc
11.1. Company Overview
11.2. Product Offerings
11.3. Financial Performance (2016-2018)
11.4. Recent Initiatives

12. Novartis (Grifols)
12.1. Company Overview
12.2. Product Offerings
12.3. Financial Performance (2016-2018)
12.4. Recent Initiatives

13. QIAGEN N.V.
13.1. Company Overview
13.2. Product Offerings
13.3. Financial Performance (2016-2018)
13.4. Recent Initiatives

14. Siemens AG
14.1. Company Overview
14.2. Product Offerings
14.3. Financial Performance (2016-2018)
14.4. Recent Initiatives

15. Sysmex Corporation
15.1. Company Overview
15.2. Product Offerings
15.3. Financial Performance (2016-2018)
15.4. Recent Initiatives

16. Thermo Fisher Scientific Inc.
16.1. Company Overview
16.2. Product Offerings
16.3. Financial Performance (2016-2018)
16.4. Recent Initiatives